SuperworthCoya Therapeutics shares outstanding COYA
Diluted shares outstanding, averaged over each quarter, from 2022.
- Latest quarter, to Jun 30, 2026
- 23.5M
- On a year earlier
- +40.3%
- more shares
Coya Therapeutics had 23.5M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 40.3% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 16.7M | +2% |
| FY2024 | 16.3M | +48% |
| FY2023 | 11M | +326% |
| FY2022 | 2.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 23.5M | +40% | |
| Q1 FY26 | 22.6M | +35% | |
| Q4 FY25 | 16.7M | +2% | |
| Q3 FY25 | 16.7M | +10% | |
| Q2 FY25 | 16.7M | +12% | |
| Q1 FY25 | 16.7M | +16% | |
| Q4 FY24 | 16.3M | +48% | |
| Q3 FY24 | 15.2M | +53% | |
| Q2 FY24 | 14.9M | +50% | |
| Q1 FY24 | 14.5M | +49% | |
| Q4 FY23 | 11M | +326% | |
| Q3 FY23 | 9.9M | +284% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Coya Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.